//
Xenotherapeutics Inc. is a private corporation based in MANCHESTER, NH. The foundation received its IRS ruling in 2018. It holds total assets of $1.8M. Annual income is reported at $4.2M. Clinical Trial: the Foundation continued to conduct the first in-human, clinical trials of live-cell, nonhuman organ transplants. The end-goal for this research is to develop and produce transplants and products to treat severe burns. The Organization's President & CEO is largely responsible for running and managing the clinical trials, along with the assistance of volunteer and outside-contracted scientists. According to available records, Xenotherapeutics Inc. has made 1 grants totaling $500, with a median grant of $500. Grant recipients are concentrated in Massachusetts. Contributions to this foundation are tax-deductible.
Clinical Trial: the Foundation continued to conduct the first in-human, clinical trials of live-cell, nonhuman organ transplants. The end-goal for this research is to develop and produce transplants and products to treat severe burns. The Organization's President & CEO is largely responsible for running and managing the clinical trials, along with the assistance of volunteer and outside-contracted scientists.
Expenses: $598K
Swine Herd Development & Material Procurement: the Foundation engaged in animal husbandry and the procurement of genetically engineered swine donors in accordance with FDA standards. The Foundation intends for its research and progress in animal husbandry and animal organ-development to improve the compatibility between patients and organ-donors.
Expenses: $36K
Education: the Foundation continued to advance public education and knowledge about xenotransplantation and its possible applications. Educational resources were provided through the Foundation's website, meetings, conferences, and other similar mediums.
Expenses: $14K
Clinical Trial: the Foundation continued to conduct the first in-human, clinical trials of live-cell, nonhuman organ transplants. The end-goal for this research is to develop and produce transplants and products to treat severe burns. The Organization's President & CEO is largely responsible for running and managing the clinical trials, along with the assistance of volunteer and outside-contracted scientists. Based on available records, the foundation has funded 1 grants. Its grantmaking reaches organizations primarily in MA.
Xenotherapeutics Inc. has distributed a total of $500 across 1 grants. The median grant size is $500, with an average of $500. Individual grants have ranged from $500 to $500.
Xenotherapeutics Inc. is a private foundation. To inquire about grants, you can look up the foundation using their EIN (811016095) on GuideStar or contact them directly. Many private foundations have specific application processes that may not be publicly listed.
Xenotherapeutics Inc. is headquartered in MANCHESTER, NH.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Jon Adkins | President & CEO | $250K | $10K | $260K |
| Jamie Love | Treasurer & CFO | $63K | $3K | $65K |
| Dr Dicken Ko | Clerk | $0 | $0 | $0 |
| Ruta Laukien | Trustee | $0 | $0 | $0 |
| Mark Nedelman | Trustee | $0 | $0 | $0 |
Total Giving
$1.3M
Total Assets
$720K
Fair Market Value
$720K
Net Worth
$90K
Grants Paid
$0
Contributions
$30K
Net Investment Income
$0
Distribution Amount
$0
Total Grants
1
Total Giving
$500
Average Grant
$500
Median Grant
$500
Unique Recipients
1
Most Common Grant
$1K
| Recipient | Location | Amount | Year |
|---|---|---|---|
| The Uss Constitution Museum IncGeneral Operating Support | Boston, MA | $500 | 2021 |
| William Deacon |
| Chairman |
| $0 |
| $0 |
| $0 |
© 2026 Granted AI